Our Pricing

Weight Loss Treatments Available Online in the UK

Published on: June 03, 2026

When you buy weight loss treatments online UK, choosing a registered pharmacy ensures you receive genuine, MHRA-licensed medications with proper clinical oversight. At Cured Pharmacy (GPhC 9012511), our superintendent pharmacist Tarun Kumar and UK-registered clinical team provide free consultations, transparent upfront pricing, and discreet delivery across the UK.

How Modern Weight Loss Medications Work

The latest generation of weight loss treatments approved by the MHRA work through sophisticated hormonal pathways that regulate appetite and metabolism. GLP-1 receptor agonists like semaglutide and liraglutide mimic natural incretin hormones, slowing gastric emptying and reducing hunger signals to the brain [1]. These medications help patients feel fuller for longer, making it easier to maintain a calorie deficit without constant hunger.

Tirzepatide represents an advancement as the first dual GIP/GLP-1 receptor agonist licensed in the UK [2]. By activating both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, it produces greater weight reduction than single-pathway treatments. In the SURMOUNT-1 trial, participants achieved an average weight loss of 22.5% over 72 weeks at the highest dose — the most substantial results seen in obesity pharmacotherapy to date [2].

Fat absorption inhibitors like orlistat work through an entirely different mechanism, blocking approximately 25% of dietary fat from being absorbed in the intestines [3]. This approach suits patients who prefer a non-hormonal option or cannot tolerate injectable medications, though it requires adherence to a reduced-fat diet to minimise gastrointestinal side effects.

Mounjaro (Tirzepatide): Clinical Evidence and UK Availability

Mounjaro contains tirzepatide, which received MHRA approval for weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [2]. The medication is administered once weekly via a pre-filled KwikPen, with doses gradually escalated from 2.5mg to a maintenance dose determined by your UK prescriber.

Clinical trial data demonstrates exceptional efficacy. In SURMOUNT-3, patients who had already lost weight through lifestyle intervention and then added tirzepatide lost an additional 18.4% of their body weight, compared to just 2.5% in the placebo group [4]. These results represent some of the most significant weight reductions achieved with pharmacotherapy, approaching outcomes previously only seen with bariatric surgery.

At Cured Pharmacy, Mounjaro is available with transparent pricing and includes a comprehensive clinical assessment by UK prescribers. All patients complete a detailed medical questionnaire covering cardiovascular history, previous weight loss attempts, current medications, and contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Who Can Take Mounjaro in the UK

UK prescribers assess suitability based on MHRA licensing criteria and NICE guidance. Suitable candidates typically have a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related condition such as type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea. Mounjaro is contraindicated in pregnancy, during breastfeeding, and in patients with a history of pancreatitis or severe gastrointestinal disease [2].

Wegovy and Saxenda: Semaglutide and Liraglutide Options

Wegovy contains semaglutide, a GLP-1 receptor agonist administered once weekly. In the STEP 1 trial, participants achieved an average weight loss of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. Wegovy is now available in both injectable and oral tablet formulations in the UK, offering flexibility for patients who prefer not to inject.

Saxenda contains liraglutide, an earlier-generation GLP-1 medication requiring daily subcutaneous injection. While daily administration may seem less convenient than weekly options, some patients prefer the ability to adjust dosing more frequently or appreciate the lower per-injection volume. In the SCALE trial, liraglutide 3.0mg daily produced an average weight loss of 8.0% over 56 weeks versus 2.6% with placebo [5].

Both medications work by reducing appetite and slowing gastric emptying, but differ in their pharmacokinetic profiles. Semaglutide has a longer half-life, allowing once-weekly dosing, whilst liraglutide's shorter duration of action necessitates daily injections. Your UK prescriber will consider your lifestyle, previous treatment responses, and medical history when recommending the most appropriate option.

Choosing Between Injectable Weight Loss Treatments

Selection depends on multiple factors including efficacy goals, injection frequency preference, side effect profile, and cost considerations. Patients seeking maximum weight reduction may benefit from tirzepatide's dual-receptor mechanism, whilst those prioritising established long-term safety data might prefer semaglutide. Daily injections with liraglutide suit individuals who want more frequent dosing control or are new to injectable medications and prefer starting with smaller volumes.

Orlistat, Xenical, and Alli: Fat Absorption Inhibitors

Orlistat works by inhibiting gastric and pancreatic lipases, enzymes responsible for breaking down dietary triglycerides in the gastrointestinal tract [3]. By blocking approximately 25% of fat absorption, it creates a modest calorie deficit whilst also encouraging patients to adopt lower-fat eating patterns to avoid gastrointestinal side effects.

The medication is available in two strengths in the UK: 120mg prescription-strength (branded as Xenical or generic orlistat) and 60mg over-the-counter strength (branded as Alli or Orlos). In clinical trials, orlistat 120mg three times daily combined with a reduced-calorie diet produced an average weight loss of 5.8kg compared to 3.0kg with placebo over one year [3].

Orlistat suits patients who prefer a non-systemic medication, have contraindications to GLP-1 treatments, or want a more affordable option for weight management. However, adherence to a diet containing no more than 30% of calories from fat is essential to minimise side effects such as oily stools, faecal urgency, and flatulence with discharge. Taking a multivitamin at bedtime helps prevent deficiencies in fat-soluble vitamins (A, D, E, K).

Starting Treatment: The UK Prescriber Assessment Process

All prescription weight loss medications available through Cured Pharmacy require clinical assessment by a UK-registered prescriber before dispensing. The online consultation takes under three minutes and covers essential medical history including cardiovascular conditions, thyroid disorders, previous weight loss attempts, current medications, and any history of eating disorders or mental health conditions.

UK prescribers evaluate multiple factors when determining suitability: current BMI and weight-related comorbidities, contraindications to specific medication classes, potential drug interactions, previous response to weight loss treatments, and realistic treatment goals. This thorough assessment ensures patient safety and optimises the likelihood of successful outcomes.

Once approved, your prescription is dispensed by our UK-registered pharmacy team under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073). Medications are dispatched in 100% discreet packaging with no external markings indicating contents, and most orders are delivered within 2-3 working days across the UK.

Ongoing Clinical Support and Monitoring

Weight loss medication is most effective when combined with lifestyle modifications including dietary changes and increased physical activity. Our clinical team provides ongoing support throughout your treatment journey, with regular check-ins to monitor progress, manage any side effects, and adjust dosing as needed. Patients are encouraged to contact the pharmacy team with any questions or concerns via phone on (+44) 116 4646009.

Pricing Transparency and UK Pharmacy Regulations

At Cured Pharmacy, all prices are displayed upfront before you complete your clinical consultation — no hidden fees or surprise charges. This transparent approach allows you to make informed decisions about your weight loss treatment without uncertainty about final costs.

As a GPhC-registered pharmacy (registration number 9012511), we operate under strict UK regulations governing the sale of prescription medications online. Every prescription is reviewed by a UK-registered prescriber, and all medications are sourced from licensed UK wholesalers, ensuring you receive genuine MHRA-approved treatments. We never supply unlicensed imports or compounded alternatives.

Our lowest price guarantee means you'll find competitive pricing across our entire weight loss range. We regularly review market rates to ensure Cured Pharmacy remains one of the most affordable options for UK patients seeking legitimate, regulated access to prescription weight loss medications with proper clinical oversight.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
4. Aronne, L. J., Sattar, N., Horn, D. B., Bays, H. E., Wharton, S., Lin, W. Y., ... & Jastreboff, A. M. (2024). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA, 331(1), 38-48. https://doi.org/10.1001/jama.2023.24945 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and lifestyle factors. Never stop or start any medication without consulting your prescriber.